Diffusion MRI for prediction of response of rectal cancer to chemoradiation

Lancet

Volumn 360, Issue 9329, 2002, Pages 307-308

  Dzik Jurasz, Andrzej ^a   Domenig, Claudia ^b   George, Mark ^c   Wolber, Jan ^a   Padhani, Anwar ^a   Brown, Gina ^a   Doran, Simon ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG EFFECT; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RECTUM CARCINOMA; TUMOR VOLUME; WATER CONTENT;

EID: 0037183247     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09520-X     Document Type: Article

References (5)

1. Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors
2. Burst excitation for quantitative diffusion imaging with multiple b-values
3. Reporting results of cancer treatment
4. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer
5. 1H-NMR spectroscopy in vivo